AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi Director's Dealing 2015

Feb 2, 2015

1643_dirs_2015-02-02_4b442724-7ee8-467a-a0c1-ed3e1069ed1d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK: 0001178670
Period of Report: 2015-01-29

Reporting Person: Sanofi (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-01-29	Common Stock	P	97118	$95	Acquired	10051603	Indirect

Footnotes

F1: Genzyme Corporation entered into a 60-day lock-up agreement (which may be extended under certain circumstances) which covers the shares acquired